212 related articles for article (PubMed ID: 31587178)
1. The effects of mitotane and 1α,25-dihydroxyvitamin D
Rubin B; Pilon C; Pezzani R; Rebellato A; Fallo F
J Endocrinol Invest; 2020 Mar; 43(3):357-367. PubMed ID: 31587178
[TBL] [Abstract][Full Text] [Related]
2. 1α,25-Dihydroxyvitamin D₃ inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer.
Pilon C; Urbanet R; Williams TA; Maekawa T; Vettore S; Sirianni R; Pezzi V; Mulatero P; Fassina A; Sasano H; Fallo F
J Steroid Biochem Mol Biol; 2014 Mar; 140():26-33. PubMed ID: 24269839
[TBL] [Abstract][Full Text] [Related]
3. Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/β-Catenin Pathways.
Oak ASW; Bocheva G; Kim TK; Brożyna AA; Janjetovic Z; Athar M; Tuckey RC; Slominski AT
Anticancer Res; 2020 May; 40(5):2467-2474. PubMed ID: 32366390
[TBL] [Abstract][Full Text] [Related]
4. The effect of 1,25-dihydroxyvitamin D3 on the Wnt signaling pathway in bovine intestinal epithelial cells is mediated by the DKK2 (dickkopf2) Wnt antagonist.
Li J; Zhang J; Zhang Y; Zhuang Y; Yan P; Zhou J; Hu S; Deng L; Zhang Z
J Steroid Biochem Mol Biol; 2023 Jul; 231():106319. PubMed ID: 37149202
[TBL] [Abstract][Full Text] [Related]
5. In vitro antitumor activity of progesterone in human adrenocortical carcinoma.
Fragni M; Fiorentini C; Rossini E; Fisogni S; Vezzoli S; Bonini SA; Dalmiglio C; Grisanti S; Tiberio GAM; Claps M; Cosentini D; Salvi V; Bosisio D; Terzolo M; Missale C; Facchetti F; Memo M; Berruti A; Sigala S
Endocrine; 2019 Mar; 63(3):592-601. PubMed ID: 30367443
[TBL] [Abstract][Full Text] [Related]
6. The lack of antitumor effects of o,p'DDA excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatment.
Hescot S; Paci A; Seck A; Slama A; Viengchareun S; Trabado S; Brailly-Tabard S; Al Ghuzlan A; Young J; Baudin E; Lombès M
Horm Cancer; 2014 Oct; 5(5):312-23. PubMed ID: 25026941
[TBL] [Abstract][Full Text] [Related]
7. Anti-adipogenic effects of 1,25-dihydroxyvitamin D3 are mediated by the maintenance of the wingless-type MMTV integration site/β-catenin pathway.
Lee H; Bae S; Yoon Y
Int J Mol Med; 2012 Nov; 30(5):1219-24. PubMed ID: 22922938
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies revealed a downregulation of Wnt/β-catenin cascade by active vitamin D and TX 527 analog in a Kaposi's sarcoma cellular model.
Tapia C; Suares A; De Genaro P; González-Pardo V
Toxicol In Vitro; 2020 Mar; 63():104748. PubMed ID: 31838186
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
[TBL] [Abstract][Full Text] [Related]
11. Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells.
Gagliano T; Gentilin E; Benfini K; Di Pasquale C; Tassinari M; Falletta S; Feo C; Tagliati F; Uberti ED; Zatelli MC
Endocrine; 2014 Dec; 47(3):943-51. PubMed ID: 25096913
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor activation is a feasible therapeutic target to impair adrenocortical tumorigenesis.
Bueno AC; More CB; Marrero-Gutiérrez J; de Almeida E Silva DC; Leal LF; Montaldi AP; Ramalho FS; Vêncio RZN; de Castro M; Antonini SRR
Mol Cell Endocrinol; 2022 Dec; 558():111757. PubMed ID: 36049598
[TBL] [Abstract][Full Text] [Related]
13. 1α,25-Dihydroxyvitamin D
Xiong Y; Zhang Y; Xin N; Yuan Y; Zhang Q; Gong P; Wu Y
J Steroid Biochem Mol Biol; 2017 Nov; 174():153-160. PubMed ID: 28859991
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation.
Hu L; Bikle DD; Oda Y
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():237-41. PubMed ID: 24239508
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 Prevents Epithelial-Mesenchymal Transition of HMrSV5 Human Peritoneal Mesothelial Cells by Inhibiting Histone Deacetylase 3 (HDAC3) and Increasing Vitamin D Receptor (VDR) Expression Through the Wnt/β-Catenin Signaling Pathway.
Liu KH; Fu J; Zhou N; Yin W; Yang YY; Ouyang SX; Liang YM
Med Sci Monit; 2019 Aug; 25():5892-5902. PubMed ID: 31391414
[TBL] [Abstract][Full Text] [Related]
16. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells.
Aguilera O; Peña C; García JM; Larriba MJ; Ordóñez-Morán P; Navarro D; Barbáchano A; López de Silanes I; Ballestar E; Fraga MF; Esteller M; Gamallo C; Bonilla F; González-Sancho JM; Muñoz A
Carcinogenesis; 2007 Sep; 28(9):1877-84. PubMed ID: 17449905
[TBL] [Abstract][Full Text] [Related]
17. 1α, 25-dihydroxyvitamin D3 inhibits transforming growth factor β1-induced epithelial-mesenchymal transition via β-catenin pathway.
Xiong XR; Tian XL; Huo RJ; Dong YT; Liu D; Bai JC; Qi YF; Tian XR
Chin Med J (Engl); 2020 Jun; 133(11):1298-1303. PubMed ID: 32452895
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
19. Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane.
van Koetsveld PM; Vitale G; Feelders RA; Waaijers M; Sprij-Mooij DM; de Krijger RR; Speel EJ; Hofland J; Lamberts SW; de Herder WW; Hofland LJ
Endocr Relat Cancer; 2013 Jun; 20(3):443-54. PubMed ID: 23507702
[TBL] [Abstract][Full Text] [Related]
20. Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells.
Kroiss M; Sbiera S; Kendl S; Kurlbaum M; Fassnacht M
Horm Cancer; 2016 Dec; 7(5-6):345-355. PubMed ID: 27631436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
